Exact Sciences Corp (NAS:EXAS)
$ 41.92 0.59 (1.43%) Market Cap: 7.74 Bil Enterprise Value: 9.64 Bil PE Ratio: 0 PB Ratio: 2.46 GF Score: 72/100

Exact Sciences Corp at Goldman Sachs Healthcare Conference Transcript

Jun 13, 2023 / 08:20PM GMT
Release Date Price: $93.57 (+2.72%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

All right. Good afternoon, everyone. Thanks for joining us. My name is Matt Sykes. I'm the life science tools and diagnostics analyst at Goldman Sachs, and I have the pleasure of welcoming Kevin Conroy, the Chairman and CEO of Exact Sciences. Kevin, thanks for being here.

Kevin T. Conroy
Exact Sciences Corporation - Chairman of The Board & CEO

Matt, thanks for having me. Thanks to Goldman Sachs, and thank all of you for attending.

Questions & Answers

Matthew Carlisle Sykes;Kevin T.
Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe if you could just kind of set the stage for us a little bit and give us an overview of the state of the business post your first quarter results. I know you've got an Investor Day coming up, but just sort of what are you seeing, the trends you saw in Q1? How are you seeing the year play out? What are some of the highlights that you want to go over?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot